Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing

M Z Khawaja1, R Rajani, A Cook

  • 1UK CoreValve Collaborative, Sussex Cardiac Centre, Brighton & Sussex University Hospital Trust, Eastern Road, Brighton, East Sussex, BN2 5BE, UK.

Circulation
|February 23, 2011
PubMed

Insights

A significant one-third of patients need a permanent pacemaker (PPM) after CoreValve transcatheter aortic valve implantation. Factors like heart block and balloon predilatation increase this risk.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Permanent pacemaker (PPM) requirement is a known complication following transcatheter aortic valve implantation (TAVI).
  • Assessing the incidence and predictors of PPM post-CoreValve TAVI is crucial for patient management.

Purpose of the Study:

  • To determine the incidence of PPM within 30 days of CoreValve implantation in the UK.
  • To develop an anatomic and electrophysiological model predicting PPM need after TAVI.

Main Methods:

  • Retrospective analysis of 270 patients undergoing CoreValve TAVI across 10 UK centers.
  • Evaluation of baseline and post-procedure ECG parameters, including QRS duration and bundle branch block incidence.
  • Multivariable analysis to identify independent predictors of PPM requirement.

Main Results:

  • 33.3% of patients required a PPM within 30 days post-procedure.
  • Significant increases in QRS duration (105 to 135 ms) and LBBB incidence (13% to 61%) were observed.
  • Independent predictors for PPM included periprocedural AV block, balloon predilatation, larger prosthesis size, increased septal diameter, and prolonged QRS duration.

Conclusions:

  • One-third of patients undergoing CoreValve TAVI require a PPM within 30 days.
  • Periprocedural AV block, balloon predilatation, larger prosthesis, increased interventricular septum diameter, and prolonged QRS duration are associated with PPM need.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
2.2K
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
1.2K
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598